References
- Yadav SP. COVID-19 in Children with Blood and Cancer Disorders: What
Do We Know So Far? J Pediatr Hematol Oncol . 2020;42(6):413-414.
doi:10.1097/MPH.0000000000001872
- Boulad F, Kamboj M, Bouvier N, Maureen A, Kung AL. COVID-19 in
Children with Cancer in New York City. JAMA Oncology .
doi:10.1001/jamaoncol.2020.2028.
- To KK, Hung IF, Ip JD, Chu AW, Chan W, Tam AR et al. COVID-19
re-infection by a phylogenetically distinct SARS-coronavirus-2 strain
confirmed by whole genome sequencing. Clinical Infectious
Diseases , ciaa1275, https://doi.org/10.1093/cid/ciaa1275
- Liu L, Wang P, Nair MS, Yu J, Rapp M, Wang Q, et al. Potent
neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike.
Nature 2020;584:450-456.
https://doi.org/10.1038/s41586-020-2571-7
- Weisblum Y, Schmidt F, Zhang F, DaSilva J, Poston D, Lorenzi JCC, et
al. Escape from neutralizing antibodies by SARS-CoV-2 spike protein
variants. bioRxiv 2020;doi: https://doi.org/10.1101/2020.07.21.214759